The Effect of Adjunctive use of Dexmedetomidine and Metoral with Thiopental on Hemodynamic Status, Agitation, and Patient Satisfaction in Patients with Mood Disorders after Electroconvulsive Therapy
AIM: The aim of our study was to determine the effect of adjunctive use of dexmedetomidine and metoral with thiopental on hemodynamic status, agitation, patient satisfaction, and duration of seizure in patients with mood disorders in electroconvulsive therapy (ECT).
METHODS: This study is a randomized, double-blind, clinical trial. Sixty patients (18–60 years) according to DSM5 criteria had mood disorder and were candidates for ECT. Patients were randomly divided into two groups of 30 each. One group received 5.0 μg/kg dexmedetomidine 10 min before induction of thiopental, and the other group received 5.2 mg intravenous metoprolol immediately before ECT. Patients’ satisfaction, duration of seizure, and arterial oxygen saturation were evaluated.
RESULTS: The mean age of both groups was approximately 37 years with the majority of men. No significant difference was found between the two groups in terms of age and sex, blood pressure (BP), heart rate (HR), duration of seizure, and arterial oxygen saturation before ECT. The mean BP and HR in the recovery were lower in the dexmedetomidine group than in the metoral group. Arterial oxygen saturation percentage was not significantly different between the two groups. The recovery time in the dexmedetomidine group was longer than the metoral group (p = 0.001). Post-ECT satisfaction was found to be higher in the dexmedetomidine group than in the metoral group and the mean agitation score was found to be higher in the metoral group.
CONCLUSION: Both metoral and dexmedetomidine as adjuvants decrease the hyperdynamic responses of patients after ECT, whereas the effect of dexmedetomidine is more than metoral; on the other hand, neither dexmedetomidine nor metoral has any negative effect on seizure duration, but dexmedetomidine significantly prolonged recovery time as compared to metoral.
Plum Analytics Artifact Widget Block
Aksay SS, Bumb JM, Remennik D, Thiel M, Kranaster L, Sartorius A, et al. Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia. Neuropsychiatr Dis Treat. 2017;13:1389-94. https:// doi.org/10.2147/ndt.s134751 PMid:28579785
McDaniel WW, Sahota AK, Vyas BV, Laguerta N, Hategan L, Oswald J. Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies. J ECT. 2006;22(2):103-6. https://doi. org/10.1097/00124509-200606000-00005 PMid:16801824
Aksay SS, Bumb JM, Jank C, Biemann R, Borucki K, Lederbogen F, et al. Serum lipid profile changes after successful treatment with electroconvulsive therapy in major depression: A prospective pilot trial. J Affect Disord. 2016;18:85-8. https:// doi.org/10.1016/j.jad.2015.09.037 PMid:26426831
Moshiri E, Modir H, Bagheri N, Mohammadbeigi A, Jamilian H, Eshrati B. Premedication effect of dexmedetomidine and alfentanil on seizure time, recovery duration, and hemodynamic responses in electroconvulsive therapy. Ann Card Anaesth. 2016;19(2):263-8. https://doi. org/10.4103/0971-9784.179618 PMid:27052067
Moy RJ, Le Clerc S. Ketamine in prehospital analgesia and anaesthesia. Trends Anaesth Crit Care. 2011;1:243-5. https:// doi.org/10.1016/j.tacc.2011.08.002
Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med. 2007;357(19):1939-45. PMid:17989386
Mohseni M, Ghanbari AS, Motazedi MA, Pournajafian A, Faiz H, Soleimani M, et al. Comparison of the effects of ketamine and thiopental on hemodynamic variables and duration of seizure in patients treated with electro-shock. Anesth Pain Acad Jihad. 2014;30:15-21.
Copeland J, Dillon P. The health and psycho-social consequences of ketamine use. Int J Drug Policy. 2005;16:122-31. https://doi. org/10.1016/j.drugpo.2004.12.003
Ibrahim L, Diazgranados N, Luckenbaugh DA, Machado-Vieira R, Baumann J, Mallinger AG, et al. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(4):1155-9. https://doi.org/10.1016/j. pnpbp.2011.03.019 PMid:21466832
Jiwanmall M, Joselyn AS, Kandasamy S. Intravenous clonidine as a part of balanced anaesthesia for controlled hypotension in functional endoscopic sinus surgery: A randomised controled trial. Indian J Anaesth. 2017;6(1):418-23. https://doi. org/10.4103/ija.ija_58_17 PMid:28584352
Wijeysundera DN, Bender JS, Beattie WS. Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database Syst Rev. 2009;7(4):CD004126. https://doi.org/10.1002/14651858. cd004126 PMid:19821319
Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: A retrospective study. Eur Arch Psychiatry Clin Neurosci. 2011;261(8):575-82. https://doi. org/10.1007/s00406-011-0205-7 PMid:21400226
Hoyer C, Kranaster L, Janke C, Sartorius A. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: A retrospective study. Eur Arch Psychiatry Clin Neurosci. 2014;264(3):255-61. https://doi.org/10.1007/ s00406-013-0420-5 PMid:23835527
Grant IS, Nimmo WS, McNicol LR, Clements JA. Ketamine disposition in children and adults. Br J Anaesth. 1983;55(11):1107-11. https://doi.org/10.1093/bja/55.11.1107 PMid:6639827
Mason KP, Robinson F, Fontaine P, Prescilla R. Dexmedetomidine offers an option for safe and effective sedation for nuclear medicine imaging in children. Radiology. 2013;267(3):911-7. https://doi.org/10.1148/radiol.13121232 PMid:23449958
Aparna AB,Thatte S, Pranita AK. Dexmedetomidine in premedication to attenuate the acute hyperdynamic response to ECT: A randomised, double-blind, controlled study. South Afr J Anaesth Analg. 2016;22:180-4. https://doi.org/10.1080/2220118 1.2016.1244316
Copyright (c) 2020 Talat Mohammadi, Hamidreza Jamilian, Anita Alaghemand, Alireza Kamali (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All rights reserved.